000166660 001__ 166660 000166660 005__ 20240229123233.0 000166660 0247_ $$2pmid$$apmid:33392079 000166660 0247_ $$2pmc$$apmc:PMC7773839 000166660 0247_ $$2doi$$a doi: 10.3389/fonc.2020.584681. 000166660 0247_ $$2doi$$adoi: 10.3389/fonc.2020.584681. 000166660 037__ $$aDKFZ-2021-00027 000166660 041__ $$aeng 000166660 082__ $$a610 000166660 1001_ $$aMayr, Lisa$$b0 000166660 245__ $$aPotential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes. 000166660 260__ $$aLausanne$$bFrontiers Media$$c2020 000166660 3367_ $$2DRIVER$$aarticle 000166660 3367_ $$2DataCite$$aOutput Types/Journal article 000166660 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1610448334_824 000166660 3367_ $$2BibTeX$$aARTICLE 000166660 3367_ $$2ORCID$$aJOURNAL_ARTICLE 000166660 3367_ $$00$$2EndNote$$aJournal Article 000166660 520__ $$aEmbryonal tumor with multilayered rosettes (ETMR) is a rare, aggressive embryonal central nervous system tumor characterized by LIN28A expression and alterations in the C19MC locus. ETMRs predominantly occur in young children, have a dismal prognosis, and no definitive treatment guidelines have been established. We report on nine consecutive patients and review the role of initiation/timing of radiotherapy on survival. Between 2006 and 2018, nine patients were diagnosed with ETMR. Diagnosis was confirmed histopathologically, immunohistochemically and molecularly. Median age was 25 months (5-38). Location was supratentorial in five, pineal in three, and brainstem in one. Seven patients had a gross total resection, one a partial resection and one a biopsy at initial diagnosis. Chemotherapy augmented with intrathecal therapy started a median of 10 days (7-20) after surgery. Only two patients who after gross total resection received radiotherapy very early on (six weeks after diagnosis) are alive and in complete remission 56 and 50 months after diagnosis. All remaining patients for whom radiotherapy was deferred until the end of chemotherapy recurred, albeit none with leptomeningeal disease. A literature research identified 228 patients with ETMR. Including our patients only 26 (11%) of 237 patients survived >36 months with no evidence of disease at last follow-up. All but two long-term (>36 months) survivors received radiotherapy, ten of whom early on following gross total resection (GTR). GTR followed by early focal radiotherapy and intrathecal therapy to prevent leptomeningeal disease are potentially important to improve survival of ETMR in the absence of effective targeted therapies. 000166660 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0 000166660 588__ $$aDataset connected to PubMed, 000166660 650_7 $$2Other$$aembryonal brain tumors 000166660 650_7 $$2Other$$aembryonal tumor with abundant neuropil and true rosette 000166660 650_7 $$2Other$$aembryonal tumor with multilayered rosette 000166660 650_7 $$2Other$$afocal radiotherapy 000166660 650_7 $$2Other$$aintrathecal therapy 000166660 650_7 $$2Other$$aradiotherapy 000166660 7001_ $$aGojo, Johannes$$b1 000166660 7001_ $$aPeyrl, Andreas$$b2 000166660 7001_ $$aAzizi, Amedeo A$$b3 000166660 7001_ $$aStepien, Natalia M$$b4 000166660 7001_ $$aPletschko, Thomas$$b5 000166660 7001_ $$aCzech, Thomas$$b6 000166660 7001_ $$aDorfer, Christian$$b7 000166660 7001_ $$0P:(DE-He78)b84967c4f073b71405404f3719c788cd$$aLambo, Sander$$b8$$udkfz 000166660 7001_ $$aDieckmann, Karin$$b9 000166660 7001_ $$aHaberler, Christine$$b10 000166660 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b11$$udkfz 000166660 7001_ $$aSlavc, Irene$$b12 000166660 773__ $$0PERI:(DE-600)2649216-7$$a10.3389/fonc.2020.584681.$$gVol. 10$$p584681$$tFrontiers in oncology$$v10$$x2234-943X$$y2020 000166660 909CO $$ooai:inrepo02.dkfz.de:166660$$pVDB 000166660 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b84967c4f073b71405404f3719c788cd$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ 000166660 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ 000166660 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0 000166660 9141_ $$y2020 000166660 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT ONCOL : 2018$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-09-06 000166660 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-06 000166660 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-06 000166660 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0 000166660 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1 000166660 980__ $$ajournal 000166660 980__ $$aVDB 000166660 980__ $$aI:(DE-He78)B062-20160331 000166660 980__ $$aI:(DE-He78)HD01-20160331 000166660 980__ $$aUNRESTRICTED